Nuwellis Inc vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? Nuwellis Inc trades at $0.55 (market cap $2.00M), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.27 (market cap $2.45B). The key difference: Energy Fuels Inc Ordinary Shares (Canada) is far larger — about 1225× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (172,259 versus 7,967,898). Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 27 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.
| NUWE | UUUU | |
|---|---|---|
Market Cap | $2.00M | $2.45B |
Volume | 172,259 | 7,967,898 |
Sector | Health | Energy |
52-Week High | $146.65 | $27.72 |
52-Week Low | $0.53 | $8.34 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | -$1.72M | $2.19B |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.621, down 7.35% today, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth with 2026 revenue reaching $9M, but continues to post significant losses with a -125.63% net income margin. Recent positive developments include strong Aquadex console adoption and expanded pediatric footprint, though cash flow remains negative requiring ongoing financing.
The outlook remains challenging with persistent losses and negative cash flow offset by promising commercial momentum. Investment opportunity hinges on the company's ability to achieve profitability while risks include execution challenges and dependence on financing. Analyst sentiment is mixed with equal buy/hold ratings reflecting the high-risk, high-reward nature of this medical technology stock.
Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.
While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.
Read more on UUUU →